X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (769) 769
Newsletter (143) 143
Book Review (100) 100
Publication (20) 20
Book / eBook (6) 6
Magazine Article (2) 2
Newspaper Article (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (704) 704
index medicus (644) 644
female (448) 448
telangiectasis (357) 357
male (353) 353
middle aged (319) 319
adult (245) 245
aged (202) 202
telangiectasis - drug therapy (159) 159
ophthalmology (154) 154
dermatology (150) 150
treatment outcome (150) 150
research (141) 141
care and treatment (125) 125
telangiectasis - pathology (105) 105
fluorescein angiography (100) 100
telangiectasis - etiology (99) 99
follow-up studies (96) 96
telangiectasis - diagnosis (89) 89
bevacizumab (84) 84
surgery (84) 84
tomography, optical coherence (83) 83
telangiectasis - therapy (81) 81
adolescent (80) 80
retrospective studies (77) 77
child (75) 75
drugs (75) 75
telangiectasis - complications (73) 73
abridged index medicus (72) 72
angiogenesis inhibitors - therapeutic use (72) 72
drug therapy (68) 68
vascular endothelial growth factor a - antagonists & inhibitors (66) 66
visual acuity (63) 63
telangiectasis - chemically induced (62) 62
cancer (61) 61
child, preschool (61) 61
reports (61) 61
ataxia telangiectasia (58) 58
intravitreal injections (58) 58
retinal telangiectasis - drug therapy (57) 57
skin - pathology (55) 55
vascular endothelial growth factor (53) 53
aged, 80 and over (52) 52
medicine & public health (52) 52
angiogenesis inhibitors - administration & dosage (51) 51
retinal telangiectasis - diagnosis (51) 51
universities and colleges (50) 50
analysis (49) 49
diagnosis (49) 49
therapy (49) 49
young adult (49) 49
skin (48) 48
oncology (47) 47
telangiectasia (46) 46
antibodies, monoclonal, humanized (44) 44
medical research (43) 43
retinal diseases - drug therapy (43) 43
diagnosis, differential (42) 42
retinal vessels - pathology (42) 42
telangiectasia, hereditary hemorrhagic - complications (42) 42
vitreous body (42) 42
injections (41) 41
time factors (41) 41
eye diseases (39) 39
patients (39) 39
administration, topical (38) 38
hereditary hemorrhagic telangiectasia (38) 38
optical coherence tomography (38) 38
photodynamic therapy (38) 38
sclerosing solutions - therapeutic use (38) 38
sclerotherapy (38) 38
medicine, experimental (37) 37
health aspects (36) 36
prospective studies (36) 36
combined modality therapy (35) 35
dermatology & venereal diseases (35) 35
disease (34) 34
ranibizumab (34) 34
telangiectasis - surgery (34) 34
infant (32) 32
juxtafoveolar retinal telangiectasis (32) 32
fundus oculi (31) 31
macular edema - drug therapy (30) 30
management (30) 30
varicose veins - therapy (30) 30
visual acuity - physiology (30) 30
animals (29) 29
antibodies, monoclonal - therapeutic use (29) 29
genetic aspects (29) 29
oncology, experimental (29) 29
risk factors (29) 29
usage (29) 29
epistaxis (28) 28
nosebleed (28) 28
retinal diseases - diagnosis (28) 28
glucocorticoids - therapeutic use (27) 27
neovascularization (27) 27
retinal vessels - drug effects (27) 27
angiogenesis inhibitors (26) 26
laser therapy (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (847) 847
French (25) 25
German (18) 18
Italian (7) 7
Russian (6) 6
Portuguese (4) 4
Spanish (3) 3
Czech (2) 2
Dutch (2) 2
Polish (2) 2
Romanian (2) 2
Danish (1) 1
Japanese (1) 1
Norwegian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2240 - 2242
Patients with the TEMPI syndrome often have a response to bortezomib or autologous hematopoietic stem-cell transplantation. In two patients with disease that... 
MEDICINE, GENERAL & INTERNAL | BORTEZOMIB | Paraproteinemias - drug therapy | Humans | Middle Aged | Telangiectasis - drug therapy | Antibodies, Monoclonal - therapeutic use | Female | Male | Antineoplastic Agents - therapeutic use | Polycythemia - drug therapy | Syndrome
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 02/2011, Volume 25, Issue 2, pp. 188 - 200
Journal Article
Journal Article
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 04/2010, Volume 24, Issue 4, pp. 453 - 459
Background Cetuximab is a chimeric human-murine monoclonal antibody against the epidermal growth factor receptor (EGFR). It has shown activities against... 
Acneiform skin eruptions | Cetuximab | Skin toxicity | Epidermal growth factor receptor | GROWTH-FACTOR RECEPTOR | epidermal growth factor receptor | skin toxicity | cetuximab | ANTIBODY | INHIBITORS | acneiform skin eruptions | DERMATOLOGY | Acneiform Eruptions - chemically induced | Eyelashes - drug effects | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Antineoplastic Agents - administration & dosage | Antibodies, Monoclonal, Humanized | Drug Eruptions - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Hair Diseases - chemically induced | Adult | Female | Paronychia - chemically induced | Drug Eruptions - etiology | Hair Diseases - drug therapy | Paronychia - drug therapy | Receptor, Epidermal Growth Factor - immunology | Emollients - administration & dosage | Telangiectasis - chemically induced | Telangiectasis - drug therapy | Conjunctivitis - chemically induced | Acneiform Eruptions - drug therapy | Conjunctivitis - drug therapy | Antibodies, Monoclonal - administration & dosage | Quality of Life | Colorectal Neoplasms - secondary | Aged | Administration, Topical | Anti-Bacterial Agents - administration & dosage | Care and treatment | Dermatology | Colorectal cancer | Dermatologic agents | Pruritus | Metastasis | Antineoplastic agents | Antimitotic agents | Complications and side effects | Cancer patients | Chemotherapy | Epidermal growth factor | Formulae, receipts, prescriptions | Monoclonal antibodies | Cancer | Index Medicus
Journal Article
Diabetologia: clinical and experimental diabetes and metabolism, ISSN 0012-186X, 07/2012, Volume 55, Issue 7, pp. 1971 - 1977
Journal Article
International Journal of Surgery, ISSN 1743-9191, 2014, Volume 12, pp. S88 - S88
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 8, pp. 778 - 780
Additional cases are reported in which bortezomib reverses many of the manifestations of the TEMPI syndrome. To the Editor: We recently described the TEMPI... 
MEDICINE, GENERAL & INTERNAL | Bortezomib | Paraproteinemias - drug therapy | Humans | Middle Aged | Telangiectasis - drug therapy | Male | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Boronic Acids - therapeutic use | Syndrome | Erythropoietin - blood | Female | Polycythemia - drug therapy | Patients
Journal Article